107 results
8-K
EX-99.1
CNTA
Centessa Pharmaceuticals plc
8 Jan 25
Regulation FD Disclosure
7:00am
and the intended advantages and benefits thereof; research and clinical development plans; the scope, progress, results and costs of developing our product
8-K
EX-99.2
CNTA
Centessa Pharmaceuticals plc
12 Nov 24
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update
7:08am
and the intended advantages and benefits thereof; research and clinical development plans; the scope, progress, results and costs of developing our product
424B5
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Prospectus supplement for primary offering
4:02pm
jurisdictions; estimates of our expenses, future revenues, capital requirements and our needs for additional financing; the potential benefits of strategic … to special rules generally intended to reduce or eliminate any benefits from the deferral of U.S. federal income tax that a U.S. Holder could derive from
8-K
EX-1.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters … , in such proportion as is appropriate to reflect not only the relative benefits referred to in clause 8(d)(i) above but also the relative fault of the Company
424B5
x3m9 9256skq42w8fieo
11 Sep 24
Prospectus supplement for primary offering
4:40pm
S-3ASR
iop81lrf8zwkix
11 Sep 24
Automatic shelf registration
4:01pm
S-3ASR
EX-4.4
muaus0
11 Sep 24
Automatic shelf registration
4:01pm
S-3ASR
EX-4.6
macg9h 6xuc2fsk7xu8
11 Sep 24
Automatic shelf registration
4:01pm
8-K
EX-99.2
lmugw6bbeug u2rwha3i
10 Sep 24
Regulation FD Disclosure
7:08am
DEFA14A
0fbpa 1qokt9t2p
20 May 24
Additional proxy soliciting materials
8:48pm
PRE 14A
i187x0r f3rqadu
26 Apr 24
Preliminary proxy
4:36pm
424B5
ajkpk
24 Apr 24
Prospectus supplement for primary offering
8:53pm
8-K
EX-1.1
9smtvs0os28
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
424B5
fbtu9a
23 Apr 24
Prospectus supplement for primary offering
5:16pm